Treatment outcome and prognostic factors of adult glioblastoma multiforme
Authors:
- Niloofar AhmadlooNANiloofar Ahmadloo
- Amir-Abbas KaniAKAmir-Abbas Kani
- Mohammad MohammadianpanahMMMohammad Mohammadianpanah
- Hamid NasrolahiHNHamid Nasrolahi
- Shapour OmidvariSOShapour Omidvari
- Ahmad MosalaeiAMAhmad Mosalaei
- Mansour AnsariMAMansour Ansari
Open Access
- 1 March 2013
- journal article
- review article
- Published by Springer Nature in Journal of the Egyptian National Cancer Institute
- Vol. 25 (1) , 21-30
Abstract
This study aimed to report the characteristics, prognostic factors and treatment outcome of 223 patients with glioblastoma multiforme (GBM). This retrospective study was carried out by reviewing the medical records of 223 adult patients diagnosed at a tertiary academic hospital between 1990 and 2008. Patients' follow up ranged from 1 to 69 months (median 11 months). Surgery was attempted in all patients in whom complete resection in 15 patients (7%), subtotal resection in 77 patients (34%), partial resection in 73 patients (33%) and biopsy alone in 58 patients (26%) were done. In addition, we performed a literature review of PubMed to find out and analyze major related series. In all, we collected and analyzed the data of 33 major series including more than 11,000 patients with GBM. There were 141 men and 82 women. The median progression free- and overall survival were 6 (95% CI=5.711-8.289) and 11 (95% CI=9.304-12.696) months respectively. In univariate analysis for overall survival, age (P=0.003), tumor size (P<0.013), performance status (P<0.001), the extent of surgical resection (P=0.009), dose of radiation (P<0.001), and adjuvant chemotherapy (P<0.001) were prognostic factors. However, in multivariate analysis, only radiation dose, extent of surgical resection, and adjuvant chemotherapy were independent prognostic factors for overall survival. The prognosis of adult patients with GBM remains poor; however, complete surgical resection and adjuvant treatments improve progression-free and overall survival.Keywords
This publication has 50 references indexed in Scilit:
- Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survivalJournal of Neurosurgery, 2011
- Glioblastoma multiforme of the elderly: the prognostic effect of resection on survivalJournal of Neuro-Oncology, 2010
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant GliomaCA: A Cancer Journal for Clinicians, 2010
- A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiformeJournal of Neurosurgery, 2010
- Glioblastoma multiforme: a review of where we have been and where we are goingExpert Opinion on Investigational Drugs, 2009
- Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastomaNeuro-Oncology, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care centerWiener klinische Wochenschrift, 2003
- Phase III Study Comparing Three Cycles of Infusional Carmustine and Cisplatin Followed by Radiation Therapy With Radiation Therapy and Concurrent Carmustine in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme: Eastern Cooperative Oncology Group Trial 2394Journal of Clinical Oncology, 2003
- The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiformeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000